Tracon Pharmaceuticals (Nasdaq: TCON) 42.3% HIGHER; Oppenheimer analyst Yigal Nochomovitz reiterated an Outperform rating and boosted his price target on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE